XELJANZ tofacitinib 5 mg Tablets

XELJANZ

Facts of XELJANZ tofacitinib 5 mg Tablets ?

• Medicine Name: XELJANZ
• Generic Name: tofacitinib
• Approval Date: Aug 21, 2012
• Company Name: Pfizer Labs.
• Available as (Form & Strength): 5 mg Tablets

What are the indications and usage?

• XELJANZ is a prescription medicine called a Janus kinase (JAK) inhibitor.
• XELJANZ is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well.
• It is not known if XELJANZ is safe and effective in people with Hepatitis B or C.
• XELJANZ is not for people with severe liver problems.
• It is not known if XELJANZ is safe and effective in children.